Costa Rica vs Lao People's Democratic Republic: Access to anti-retroviral drugs, male
Costa Rica
61.0%
in 2024
Lao People's Democratic Republic
61.0%
in 2024
Costa Rica rank
97th
Lao People's Democratic Republic rank
97th
Access to anti-retroviral drugs, male over time
- Costa Rica
- Lao People's Democratic Republic
How they compare
Costa Rica currently reports 61.0% against 61.0% in Lao People's Democratic Republic, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 97th and Lao People's Democratic Republic ranks 97th of 141 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.6% | 5.8% | 10.8% | Costa Rica |
| 2010s | 40.8% | 25.4% | 15.4% | Costa Rica |
| 2020s | 59.2% | 51.4% | 7.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Costa Rica or Lao People's Democratic Republic?
- Costa Rica, at 61.0% against 61.0% in Lao People's Democratic Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Costa Rica and Lao People's Democratic Republic?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Lao People's Democratic Republic?
- 24 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Lao People's Democratic Republic rank globally for access to anti-retroviral drugs, male?
- Costa Rica ranks 97th and Lao People's Democratic Republic ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.